Pleconaril

N/A

Report date: 2022/07/06 17:25:47
NME

Base Information

Drug NamePleconaril
Drug Alias NamePicovir普利康那利普来可那立Pleconarilum普可那利 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsRhinovirus infectionAsthmaEnterovirus Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViropharmaNational Institute Of Allergy And Infectious Diseases (Niaid)Merck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsRhinovirus infectionAsthmaEnterovirus Infections +[5] 

Other Information

ATC CodeJ05AX06
Related LinksWikipediaDrugBankKEGG